MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by VectivBio AG

News headline image
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Publishes Invitation to the Annual General Meeting
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Announces Results of Extraordinary General Meeting
From VectivBio AG
Via GlobeNewswire
Tickers FRBN NAMS VECT
News headline image
VectivBio Publishes Invitation to the Extraordinary General Meeting of Shareholders
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio to Present at the 2022 Jefferies London Healthcare Conference
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Announces Completion of Enrollment for Colon-In-Continuity (CIC) Cohort of STARS Pivotal Phase 3 Study Investigating Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF)
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Reports Positive Interim Clinical Data from STARS Nutrition, a Phase 2 Study Investigating Apraglutide in Short Bowel Syndrome with Intestinal Failure Patients (SBS-IF) with Colon-In-Continuity (CIC)
From VectivBio AG
Via GlobeNewswire
Tickers VECT
News headline image
VectivBio Announces Date of Extraordinary General Meeting of Shareholders
From VectivBio AG
Via GlobeNewswire
Tickers VECT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story